Sotuvning sof marjinal rentabelligi: Wave Life Sciences (WVE)

WVE (Wave Life Sciences) - kompaniyaning tovar belgisi

Wave Life Sciences genetik nuqsonlarni tuzatish uchun PRISM platformasini ishlab chiqmoqda, bu esa uning yuqori ilmiy salohiyatini tasdiqlaydi. Choraklik savdo marjalari foyda dinamikasini namoyish etmoqda, bunda -296.90 belgisi joriy ko'rsatkich vazifasini o'taydi. Daromadlar neyrodegenerativ patologiyalarni davolash uchun sog'liqni saqlash gigantlaridan keladigan to'lovlarga asoslangan. Aniqlikdagi RNK tibbiyotiga bo'lgan yuqori qiziqish global korporatsiyalar bilan hamkorlik tarmog'ining kengayishiga turtki bermoqda.

Wave Pharma (WVE) Sotuvning sof rentabelligi: 04.07.2022 - 19.11.2026 davri uchun

Wave Life Sciences kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Wave Life Sciences Ltd, WVE
Wave Life Sciences Corp yetakchi tovari

Wave Life Sciences (WVE) tomonidan RNA terapiyasi klinik sinovlariga kiritilgan faol investitsiyalar vaqtincha operatsion yuklamani oshirmoqda, bu esa bevosita yakuniy daromadliroqlikka ta'sir qiladi. Ushbu ko'rsatkich har bir dollar daromadning sof foyda ulushini o'lchaydi va xarajatlarni boshqarish samaradorligini baholash imkonini beradi; shuning uchun, sof foyda marjasidagi tendentsiya biznesning daromadli bosqichga o'tish vaqtini aniqlash uchun asosiy signal vazifasini o'taydi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX